Praxis promotes Sniecinski to COO; adds Kindler and Arbuckle to board

Praxis Precision Medicines, Inc.

Megan Sniecinski promoted to COO effective Jan 1, 2026; previously CBO since Dec 2021.
Sniecinski's base salary increased to $626,000, target bonus 50% of salary for 2026.
Jeffrey B. Kindler elected to Board as Class II director, effective Jan 8, 2026; deemed independent.
Stuart A. Arbuckle elected to Board as Class II director, effective Jan 8, 2026; deemed independent.
Kindler and Arbuckle entitled to initial stock option awards and annual retainers per company policy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.